You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 115 No. 10, October 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psoriasis, Polymorphonuclear Leukocytes, and Lithium Carbonate

An Important Clue

Gerald S. Lazarus, MD; Robert S. Gilgor, MD

Arch Dermatol. 1979;115(10):1183-1184.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

One of the characteristic histologic features of psoriasis is the accumulation of polymorphonuclear leukocytes in the stratum corneum. A major clinical feature of patients with pustular psoriasis or irritated psoriasis vulgaris is migration of polymorphonuclear leukocytes into the skin. The role of polymorphonuclear leukocytes in the pathogenesis of psoriasis is unknown, but a number of observations imply that these cells might be important in the development of clinical lesions.

Recently, there has been tremendous interest in the mechanisms by which polymorphonuclear leukocytes are attracted to the epidermis in psoriasis. Tagami and Ofuji1 have demonstrated that psoriatic scale contains leukotactic substances that appear to be products of complement activation. One possible mechanism for the production of these chemoattractant complement peptides by psoriatic skin could be the release or activation of an epidermal proteolytic enzyme that activates complement by a nonimmunologic mechanism.2 Extracts of parenchymatous tissues and cells are chemotactic . . . [Full Text PDF of this Article]


Author Affiliations

Durham, NC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.